C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/1999
11/23/1999	US5989807 Polymerase chain reactions
11/23/1999	US5989805 Immortal avian cell line to grow avian and animal viruses to produce vaccines
11/23/1999	US5989804 E6 binding proteins
11/23/1999	US5989561 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
11/23/1999	US5989554 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
11/23/1999	US5989553 Expression library immunization
11/23/1999	US5989537 Methods for stimulating granulocyte/macrophage lineage using thrombopoietin
11/23/1999	US5989499 Dual chamber disposable reaction vessel for amplification reactions
11/23/1999	US5989431 Method and apparatus for DNA extraction
11/23/1999	CA2167838C Methods for enhancing nucleic acid amplification
11/23/1999	CA1340827C Diagnostic methods for detecting lymphomas in humans
11/20/1999	CA2238289A1 Biocontrol agent and fungicide for blackleg disease
11/19/1999	CA2270409A1 Novel mutations relating to x-linked charcot-marie-tooth disease
11/18/1999	WO1999059037A1 Methods of determining protein activity levels using gene expression profiles
11/18/1999	WO1999058978A2 Tumour markers
11/18/1999	WO1999058972A1 Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
11/18/1999	WO1999058971A2 Methods for quantitating low level modifications of nucleotide sequences
11/18/1999	WO1999058947A2 Modulation of molecular interaction sites on rna and other biomolecules
11/18/1999	WO1999058725A1 Process for obtaining amplified fragments of nucleic acid of viral and sub-viral particles which contain rna
11/18/1999	WO1999058724A1 A method for synthesizing a nucleic acid molecule using a ribonuclease
11/18/1999	WO1999058723A1 Heteroduplex mutational vectors and use thereof in bacteria
11/18/1999	WO1999058722A1 Characterization of interactions between molecular interaction sites of rna and ligands therefor
11/18/1999	WO1999058721A1 Multiplex dna amplification using chimeric primers
11/18/1999	WO1999058720A1 Quantitative methods, systems and apparatuses for gene expression analysis
11/18/1999	WO1999058719A1 Identification of molecular interaction sites in rna for novel drug discovery
11/18/1999	WO1999058718A1 Method for identifying genes
11/18/1999	WO1999058717A1 Method for identifying nucleic acid molecules
11/18/1999	WO1999058716A1 Method for quantitating specific gene sequence and quantitating reagent
11/18/1999	WO1999058715A1 Polymorphism in a nitric oxide synthase gene
11/18/1999	WO1999058714A2 Method for screening for inhibitors and activators of type iii secretion machinery in gram-negative bacteria
11/18/1999	WO1999058713A2 Method for detecting microorganisms in products
11/18/1999	WO1999058712A2 Detection of genes
11/18/1999	WO1999058711A1 Method for diagnosing or assessing a predisposition to alzheimer's disease
11/18/1999	WO1999058710A1 7-alkoxycoumarins as cytochrome p450 substrates
11/18/1999	WO1999058709A1 Test strip
11/18/1999	WO1999058708A1 Methods for identifying pathways of drug action
11/18/1999	WO1999058692A2 Human apoptosis associated proteins
11/18/1999	WO1999058688A2 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
11/18/1999	WO1999058683A2 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
11/18/1999	WO1999058680A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor
11/18/1999	WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
11/18/1999	WO1999058675A2 Human genes and gene expression products v
11/18/1999	WO1999058665A2 Isolation and use of fetal urogenital sinus expressed sequences
11/18/1999	WO1999058663A1 METHODS AND COMPOSITIONS FOR SCREENING FOR MODULATORS OF IgE SYNTHESIS, SECRETION AND SWITCH REARRANGEMENT
11/18/1999	WO1999058647A2 Human deadenylating nuclease, its production and its use
11/18/1999	WO1999058641A2 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999	WO1999058559A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity
11/18/1999	WO1999058558A2 Cell signaling proteins
11/18/1999	WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999	WO1999058474A1 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds
11/18/1999	WO1999058124A1 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
11/18/1999	WO1999053097A3 Method for developing degenerate pcr primers
11/18/1999	WO1999053096A3 Poliovirus serotype-specific nucleic acids and methods for detecting specific serotypes of poliovirus
11/18/1999	WO1999053044A3 High throughput dna sequencing vector
11/18/1999	WO1999050662A3 Method of measuring bone resorption rate
11/18/1999	WO1999050439A3 Anthrax lethal factor is a mapk kinase protease
11/18/1999	WO1999050385A3 Regulation of glycosaminoglycan synthesis, methods and reagents related thereto
11/18/1999	WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999	WO1999049888A3 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
11/18/1999	WO1999048915A9 Orphan nuclear receptor
11/18/1999	WO1999047683A9 Gene encoding labyrinthin, a marker for cancer
11/18/1999	WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999	WO1999047649A9 Polymerase chimeras
11/18/1999	WO1999047643A9 Selection subtraction approach to gene identification
11/18/1999	WO1999047637B1 Microbiological testing of a liquid sample
11/18/1999	WO1999047557A3 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins
11/18/1999	WO1999046402A3 Water-soluble coumarin fluorescent enzyme substrates
11/18/1999	WO1999046364A9 Vascular endothelial growth factor 2
11/18/1999	WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999	WO1999043830A3 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
11/18/1999	WO1999042620A3 Articles of manufacture and methods for staining biomolecules
11/18/1999	WO1999042584A9 Apoptosis inducing molecule ii and methods of use
11/18/1999	WO1999042571A8 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1
11/18/1999	WO1999038981A3 Human protein kinase molecules
11/18/1999	WO1999037803A9 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
11/18/1999	WO1999036550A3 Human protease molecules
11/18/1999	WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999	WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999	DE19820982A1 Detection of genes by amplification with primers specific for CpG islands and that incorporate restriction enzyme recognition sequences
11/18/1999	CA2404693A1 97 human secreted proteins
11/18/1999	CA2334830A1 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
11/18/1999	CA2331824A1 Test strip
11/18/1999	CA2331754A1 Methods of determining protein activity levels using gene expression profiles
11/18/1999	CA2331621A1 Methods for identifying pathways of drug action
11/18/1999	CA2331510A1 Quantitative methods, systems and apparatuses for gene expression analysis
11/18/1999	CA2331508A1 Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
11/18/1999	CA2331315A1 Identification of molecular interaction sites in rna for novel drug discovery
11/18/1999	CA2328589A1 Heteroduplex mutational vectors and use thereof in bacteria
11/18/1999	CA2328588A1 Polymorphism in a nitric oxide synthase gene
11/18/1999	CA2328508A1 Nucleic acid molecules encoding wheat enzymes involved in starch synthesis
11/18/1999	CA2328492A1 Human deadenylating nuclease, its preparation and use
11/18/1999	CA2328481A1 Methods and compositions for screening for modulators of ige synthesis, secretion and switch rearrangement
11/18/1999	CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999	CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/18/1999	CA2328146A1 Method for identifying nucleic acid molecules
11/18/1999	CA2327548A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999	CA2327354A1 Human apoptosis associated proteins
11/18/1999	CA2327351A1 Cell signaling proteins
11/18/1999	CA2271256A1 Cloning vector, its preparation and use for mrna expression pattern analysis
11/17/1999	EP0957366A1 Novel method for measuring enzyme reaction

1 ... 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 ... 3003